Skip to main content
Premium Trial:

Request an Annual Quote

Think Twice (Or Three Times) Before You Buy

With an ever growing number of genetic tests being marketed directly to consumers — check out this story in the Wall Street Journal that reports on Myriad Genetics’ breast-cancer-gene test seeing a 55% increase in sales after an $8 million advertising blitz — people are going to have to be even more discriminating. Should they be spending money, and more importantly, concern, taking tests that may or may not be useful, asks this article in Wired. People are advised to check in with a genetic counselor before having the test to weigh the pros and cons. Some experts still aren't hopeful, though. "Some of these tests are complete rubbish," says Howard McLeod, a personalized medicine specialist. "The big challenge for a consumer is figuring out which data is real or not without having to go to medical school."


The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.